| Market Cap | 513M 451M 416M 384M 727M 48.94B 740M 4.95B 1.94B 23.97B 1.93B 1.88B 83.13B | P/E 2017 |
-17.4x | P/E 2018 | -41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 460M 404M 373M 344M 652M 43.88B 664M 4.44B 1.74B 21.49B 1.73B 1.69B 74.53B | EV / Sales 2017 |
53,919,197x | EV / Sales 2018 | 19,487,976x |
| Free-Float |
80.58% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -8.86% | - | - | 352M | |
| +0.95% | -0.08% | -12.93% | -8.82% | 12.85B | |
| +2.42% | +1.37% | -33.67% | -54.78% | 4.79B | |
| -0.02% | -0.64% | -7.44% | -9.90% | 4.4B | |
| +2.11% | -0.70% | +3.95% | -37.98% | 3.82B | |
| -7.84% | -7.31% | +11.66% | -9.08% | 3.68B | |
| -0.58% | +6.63% | -8.62% | -12.78% | 3.26B | |
| +0.28% | +0.57% | -11.17% | +2.10% | 3.1B | |
| -0.77% | +1.24% | -8.23% | -23.20% | 2.41B | |
| -0.32% | +4.78% | -5.15% | +44.22% | 1.8B | |
| Average | -0.38% | -1.14% | -7.95% | -12.25% | 4.46B | |
| Weighted average by Cap. | -0.01% | -1.26% | -9.82% | -15.18% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 3.08 2.7 2.49 2.3 4.36 293.55 4.44 29.7 11.65 143.77 11.56 11.3 498.58 | 18.69 16.41 15.14 13.98 26.49 1.78K 26.96 180.38 70.75 873.13 70.18 68.65 3.03K |
| Net income | -8.89M -7.81M -7.2M -6.65M -12.6M -848M -12.83M -85.8M -33.66M -415M -33.38M -32.66M -1.44B | -8.41M -7.39M -6.82M -6.29M -11.92M -802M -12.14M -81.19M -31.85M -393M -31.59M -30.9M -1.36B |
| Net Debt | -1.84M -1.61M -1.49M -1.38M -2.61M -175M -2.65M -17.74M -6.96M -85.89M -6.9M -6.75M -298M | -53.08M -46.6M -43M -39.69M -75.2M -5.06B -76.56M -512M -201M -2.48B -199M -195M -8.6B |
Employees
-
Sector
Pharmaceuticals
Choose MarketScreener 
